MAM
NTLA icon

Meeder Asset Management’s Intellia Therapeutics NTLA Stock Holding History

Meeder Asset Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-233
Closed -$4.79K – 984
2024
Q3 		$4.79K Buy
233
+84
+56% +$1.94K ﹤0.01% 747
2024
Q2 		$3.33K Buy
149
+26
+21% +$619 ﹤0.01% 816
2024
Q1 		$3.38K Buy
+123
New +$3.42K ﹤0.01% 686
2021
Q4 		– Sell
-1,931
Closed -$258K – 1946
2021
Q3 		$258K Sell
1,931
-151
-7% -$22.9K 0.01% 648
2021
Q2 		$337K Buy
2,082
+318
+18% +$24.8K 0.02% 610
2021
Q1 		$142K Buy
+1,764
New +$118K 0.01% 820
2020
Q4 		– Sell
-3,517
Closed -$69K – 2110
2020
Q3 		$69K Sell
3,517
-343
-9% -$7.15K ﹤0.01% 885
2020
Q2 		$80K Buy
3,860
+3,753
+3,507% +$63.8K 0.01% 812
2020
Q1 		$1K Buy
+107
New +$1.44K ﹤0.01% 2206
2019
Q3 		– Sell
-119
Closed -$2K – 2231
2019
Q2 		$2K Buy
+119
New +$1.87K ﹤0.01% 1874
2018
Q4 		– Sell
-11
Closed – – 1768
2018
Q3 		$0 Buy
+11
New +$320 ﹤0.01% 1641
2018
Q2 		– Sell
-77
Closed -$2K – 1640
2018
Q1 		$2K Sell
77
-218
-74% -$5.36K ﹤0.01% 1383
2017
Q4 		$6K Buy
295
+126
+75% +$2.91K ﹤0.01% 1266
2017
Q3 		$4K Sell
169
-149
-47% -$2.81K ﹤0.01% 1326
2017
Q2 		$5K Sell
318
-69
-18% -$964 ﹤0.01% 1196
2017
Q1 		$5K Hold
387
– – ﹤0.01% 1081
2016
Q4 		$5K Buy
+387
New +$5.81K ﹤0.01% 857

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meeder Asset Management's NTLA Position: Q4 2024 in Review

Meeder Asset Management sold out of Intellia Therapeutics (NTLA) in Q4 2024, closing a stake of 233 shares — an estimated $4.79K sold.

Meeder Asset Management first reported a position in NTLA in Q4 2016 and held it in 17 quarters. The position peaked at $337K in Q2 2021. 293 funds tracked by Wall St. Rank hold NTLA as of Q4 2024.

  • Meeder Asset Management reported no remaining Intellia Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Meeder Asset Management sold 233 Intellia Therapeutics shares in Q4 2024, an estimated $4.79K.
  • Meeder Asset Management first reported a position in Intellia Therapeutics in Q4 2016 and held it in 17 quarters.
  • Meeder Asset Management's Intellia Therapeutics position peaked at $337K in Q2 2021.
  • 293 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q4 2024.

Based on Meeder Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.